The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for emapalumab-Izsg for use in adult and ...
(MEMPHIS, Tenn. – March 6, 2024) Hemophagocytic lymphohistiocytosis (HLH) is a rare and often aggressive syndrome of hyperactive inflammation with up to a 40% mortality rate. Scientists at St. Jude ...
Dublin, April 02, 2026 (GLOBE NEWSWIRE)-- The "Hemophagocytic Lymphohistiocytosis Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive insights into ...
The family of 17-year-old Waseh Sultani said he “courageously battled” a rare disease called hemophagocytic lymphohistiocytosis ...
Please provide your email address to receive an email when new articles are posted on . Mortality due to hemophagocytic lymphohistiocytosis nearly doubled across Europe over a recent 10-year period.
Macrophage activation syndrome (MAS) is a rare but serious complication that can happen in people with Still's disease. Still's disease is a type of inflammatory condition that causes daily fevers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results